Is there a gender difference in non-small cell lung cancer survival?

Chatkin, José Miguel; Abreu, Carolina Mariante de; Fritscher, Carlos Cézar; Wagner, Mário Bernardes; Pinto, Josuel Alfredo Vilela

doi:10.1016/s1550-8579(04)80009-3

Cited by 29 publications

(18 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Previous studies have suggested that women have better prognosis in general for lung cancer than men [15,16]. The gender difference of smoking cessation effect was consistent with the Mayo study [10].…”

Section: Discussionsupporting

confidence: 87%

See 1 more Smart Citation

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients

Zhou¹,

Heist

Liu

et al. 2006

Lung Cancer

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 87%

“…Ex-smokers were classified into three groups by tertiles of smoking cessation(1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17), and ≥18 years).b Median and range, by Kruskal-Wallis test. c Frequency, tested by Pearson 2 -test.…”

mentioning

confidence: 99%

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients

Zhou¹,

Heist

Liu

et al. 2006

Lung Cancer

View full text Add to dashboard Cite

“…The postoperative prognosis of female patients with NSCLC is reportedly better than that of male patients (17)(18)(19). Moreover, the smoking rate in female patients was found to be significantly lower than that in males (19).…”

Section: Discussionmentioning

confidence: 88%

Complete resection of the primary lesion improves survival of certain patients with stage IV non-small cell lung cancer

et al. 2017

View full text Add to dashboard Cite

Background:The standard treatment for patients with stage IV non-small cell lung cancer (NSCLC) is systemic chemotherapy. However, certain patients, such as those with oligometastasis or M1a disease undergo resection of the primary lesion. Results: The median follow-up duration for the 38 patients (27 men) was 17.7 months (range, 1-82.3 months). The T factors were T1/T2/T3/T4 in 4/16/12/6 patients, respectively. The N factors were N0/N1/N2/N3 in 16/8/12/2 patients, respectively. The M factors were M1a/M1b/M1c in 19/13/6 patients, respectively. Of the 19 M1a patients, 11 were classified as cM0. We introduced the novel classification M-better/M-worse. M-better includes cM0 patients and M1b and M1c patients in whom all lesions have been locally controlled. M-worse includes cM1a patients and M1b and M1c patients in whom lesions cannot be locally controlled. The new M-better/M-worse statuses were 24/14 patients, respectively. The histology of NSCLC was adenocarcinoma/squamous cell carcinoma/others in 30/5/3 patients, respectively. The 5-year overall survival rate was 29%, and the median survival time was 725 days. Squamous cell carcinoma and M-worse were significant factors predicting poor outcomes (P=0.0017, P=0.0007, respectively).Conclusions: Even for stage IV NSCLC patients, resection of the primary lesion may be beneficial, especially for those with M-better status and those not diagnosed with squamous-cell carcinoma (SCC).

show abstract

“…To date, there are a large number of publications suggesting that women diagnosed with NSCLC (10)(11)(12)(13)(14) small-cell lung cancer (15)(16)(17)(18)(19)(20)(21) have a better prognosis than men. With specific reference to brain metastases and NSCLC, there are retrospective studies suggesting that female gender may have a positive impact on outcomes (22)(23)(24)(25).…”

Section: Discussionmentioning

confidence: 99%

Gender, Race, and Survival: A Study in Non–Small-Cell Lung Cancer Brain Metastases Patients Utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification

Videtic

Reddy

Chao

et al. 2009

International Journal of Radiation Oncology*Biology*Physics

View full text Add to dashboard Cite

Is there a gender difference in non-small cell lung cancer survival?

Cited by 29 publications

References 28 publications

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients

Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients

Complete resection of the primary lesion improves survival of certain patients with stage IV non-small cell lung cancer

Gender, Race, and Survival: A Study in Non–Small-Cell Lung Cancer Brain Metastases Patients Utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification

Contact Info

Product

Resources

About